Bold Business Logo

CMS and Direct Contracting Models – Is This the Future of Healthcare?

For several decades, one of the most pressing political agendas has involved healthcare system reform. Going back to the Clinton administration, efforts to fix what appears to be an inefficient and expensive approach to healthcare. Major reforms occurred with Obamacare, and additional changes have since focused on various Medicare programs. Gradually, some progress has been made, but underneath it all, a fee-for-service structure has plagued effective change. The pandemic has made this even more evident over the last year and served as a catalyst in this regard. But the direct contracting model recently introduced by the Center for Medicare and Medicaid Services (CMS) may finally change that. And if successful, it may perhaps represent the future of healthcare in the U.S.

(Read more about the positive impact the pandemic has had on healthcare innovation in this Bold story.)

Direct contracting is a new model introduced this year by CMS that expands its prior accountability care organization (ACO) approaches. In many ways, it’s quite similar to ACOs, but it is also different in some very important ways. By finally eliminating a fee-for-service foundation, direct contracting lets healthcare organizations and providers focus more on value and patient outcomes. As a result, incentives encourage more of a preventative and health promotion approach to the future of healthcare. Notably, this has great potential in improving efficiency, results, and cost-effectiveness.

“By aligning payments with positive health outcomes, value-based care creates incentives for providers to keep people healthy and out of the hospital. It encourages physicians to come up with innovative solutions.” – Toyin Ajayi, M.D., Chief Health Officer and Cofounder, Cityblock

Direct Contracting Eliminates Fee-For Service

The direct contracting model introduced by CMS represents a new approach in caring for Medicare beneficiaries. Previously, both Medicare Advantage plans and ACOs attempted to create a value-based healthcare system for these patients. But both have limitations that prevented them from realizing cost and quality outcome goals. While both made healthcare organizations and payers more accountable, problems remained. Because both systems still paid providers based on a fee-for-service model, incentives to perform more services remained. As a result, a shift to value-based care was quite limited.

The reason many believe direct contracting reflects the future of healthcare involves the fact that fee-for-service reimbursements have been eliminated. In this new model, CMS contracts directly with a direct contracting entity (DCE), which is a larger healthcare system or insurer. DCEs then partner with direct contracting participant providers (DCPPs), which may be physicians, medical practices, hospices, or home health agencies. CMS pays the DCE a flat rate for each Medicare patient that the DCE covers at regularly intervals. This is known as a capitated model of care rather than a fee-for-service one. Thus, no matter how many services are rendered each month, DCEs still get the same amount from CMS.

“This model allows participating entities to build integrated relationships with healthcare providers and invest in population health in a region to better coordinate care, improve quality and lower the cost of care for Medicare beneficiaries in a community.” – Seema Verma, CMS Administrator

Direct Contracting Changes Healthcare Incentives

It’s been quite clear for some time that fee-for-service models are unsustainable for the future of healthcare. These models encourage providers to focus on diagnostic and treatment services because this generates compensation. In contrast, however, providers have no incentives to perform more services under direct contracting models. Instead, they can earn higher rewards for providing high-value care that results in optimal patient outcomes for less money. Direct contracting therefore encourages providers of all types to work together at providing the least amount of services that yield the best results. These types of value-based changes are what many believe will be required for the future of healthcare.

The word Medicare spawning all these other words
The future of healthcare–especially as it pertains to Medicare–lies with the direct contracting model.

The direct contracting model lets DCEs share in the savings they generate for CMS. Each year, CMS determines a performance year benchmark for the DCE. If the DCE spends less money than the benchmark, they get to have some or all of the savings. This is provided to them as a bonus at the end of the year by CMS. However, at the same time, if they exceed benchmark spending, the DCE will have to reimburse CMS money. This is how direct contracting models hold healthcare organizations and provider accountable. And this is what creates a system that is more focused on value rather than the number of services rendered. In essence, CMS wants the future of healthcare to be one where all stakeholders share some risk.

“This meaningful shift presents an opportunity for primary care providers across the country to assess their potential economics in direct contracting and, more importantly, manage their patients more holistically and with less administrative burden.” – Michael Kopko, CEO, Pearl Health

The Future of Healthcare Vision

The new model for value-based healthcare creates an environment that is actually better for all involved. By receiving a set payment for month, DCEs and providers can use this revenue that best serves them and their patients. Many providers appreciate how such a value-based model would have been helpful during the pandemic. Reportedly, providers saw a 32 percent reduction in fee-for-service revenues during this time. But if a value-based, direct contracting model had been in place, revenues would have remained steady. Notably, many healthcare companies recognize these advantages under direct contracting. Specifically, businesses like Pearl Health are helping organizations and providers alike navigate this new system to their advantage.

CMS naturally hopes direct contracting will prove to be highly effective for Medicare populations. If it does, their vision for the future of healthcare involves expanding this model to private industry. This is not likely to be a hard sale, given that many organizations and providers are already on board. Despite understanding that direct contracting models are far from perfect, they believe value-based healthcare is the future of healthcare. And thus far, CMS’ new model for Medicare seems to have the greatest potential of realizing this for all of healthcare.

 

The official Bold Business survey results are clear: most favor work-from-home over going back to the office. Read more in this important Bold story!

Wherefore Art Thou, Indoor Dining?

After more than a year of significant indoor dining restrictions, restaurants though the worst was over. Patrons, many of whom were vaccinated, enjoyed some return to normalcy as indoor seating returned. But it appears the moment may have been fleeting. Many communities are having significant increases in the number of COVID cases associated with the delta variant. And as a result, indoor dining and COVID restrictions are once again back in place. This not only applies to individual restaurants but to some franchisees and entire cities as well.

The constant changes in policies related to indoor dining and COVID restrictions are enough to make customers’ heads spin. Depending on where one is, the rules seem to change. Plus, with so much variation in delta variant infection rates, customers must also weigh their own specific risks. As a result, indoor dining restrictions are anything but consistent, and naturally, there are major differences in opinions. But one thing is certain…indoor dining is anything but normal. And customers are not likely to feel completely comfortable dining indoors for some time to come.

“We’re monitoring the impact of the Delta variant closely and recently convened together with our franchisees to underscore existing safety protocols, reinforce our people first approach and provide updates on the rise in cases in the country.” – McDonald’s Corp

Major Restaurant Chains and COVID Restrictions

One of the more challenging aspects of indoor dining restrictions involve determining nation-wide policies. When the pandemic first struck, many fast-food restaurant chains quickly shut down seating inside. This was not only to protect patrons but also their own staff. Fortunately, most were able to survive by switching to delivery, drive-through, and takeout. Once the vaccination became available, most then reopened indoor dining and COVID restrictions lifted. But now, many such chains are having to reevaluate the best approach given the situation currently. Because of regional variations, this has been difficult.

(Read more on how the food service industry has adapted to the curveballs thrown by the pandemic in this Bold story.)

Recently, McDonalds held a conference call with all of its franchisees. Though the company hoped to fully lift all indoor dining restrictions by Labor Day, this has since changed. Company representatives have instructed franchisees who have more than 250 COVID cases per 100,000 people to close indoor dining. PMTD, which operates Taco Bell and KFC, have also had to revisit indoor dining and COVID policies. In Alabama and Georgia, they restricted hours of operation, closing as early as 8pm. As a significant number of employees contracted the delta variant, they had little choice. And given that late-night dining is nearly a fifth of sales, the decision was a tough one to make.

“There is no magic bullet, just a combination of a hard stick and soft stick. The proof of vaccination mandate is a soft stick because you can still eat outdoors, but if you want to hang out with people indoors you better get vaccinated.” – Dr. Peter Chin-Hong, Infectious Disease Expert, University of California, San Francisco

Indoor Dining and COVID Changes in Major Cities

While fast-food chains like McDonalds and PMTD have the own struggles, so do local restaurants. Some cities are now requiring proof of COVID vaccination in order to dine inside a restaurant. San Francisco was the first to do so recently as part of their indoor dining restrictions. This has required restaurant managers to develop new processes to ensure their compliance with the city’s law. In some cases, they have had to hire additional employees. Of course, non-vaccinated patrons can still seat outdoors and dine, if it’s available. But these indoor dining and COVID restrictions are certainly another issue with which restaurants are having to deal.

A bunch of people socially distancing in a restaurant
Mixing indoor dining and COVID has been a rough ride, but hopefully things will change for the better.

San Francisco is not the only city that is imposing new indoor dining and COVID policies. In New Orleans, the city requires either proof of vaccination or a negative COVID test for indoor dining or drinking. In New York City, those who want to dine indoors must have at least partial vaccination. As is evident, more and more cities are requiring these indoor dining restrictions to be in place. The majority of restaurant managers welcome these protections, particularly for their own staff. But at the same time, they’re naturally concerned it could affect their business.

“It’s frustrating for diners and for restaurants right now. We don’t have an adequate supply chain. We’re figuring we’re going to be shorthanded. For us to be able to deliver on a great customer experience is hard enough when the guests are happy.” – Larry Reinstein, Restaurant Consultant

Making a Good Choice About Indoor Dining

Understandably, both restaurant chains and cities want to be proactive in adjusting indoor dining and COVID policies. But given the fact so many factors are at play, it’s impossible to do this well on an individual basis. Overall, the number of COVID cases recently increased 3% while hospitalizations increased 6%. But these numbers vary significantly from one community to the next. And those with serious illness tend to be those who are unvaccinated and/or have concurrent medical conditions. Each of these must be considered when making a decision about indoor dining. In some instances, virtual dining may be the better option.

The best-case scenario for indoor dining safety is one where the majority are vaccinated, good ventilation exists, and servers are masked. This has been shown to have the lowest risk of spreading the virus. This is why many cities and franchises are imposing indoor dining restrictions to make such a situation more likely. But each person should also consider their own personal risks since restaurants are unable to do so. This means learning about the community’s current rate of infection and considering one’s own health status. Indoor dining and COVID restrictions are not likely to go away for the foreseeable future. And therefore, this remains the best strategy for now.

 

The official Bold Business survey results are clear: most favor work-from-home over going back to the office. Read more in this important Bold story!

The Latest Breakthrough in Cancer Treatment – Good News Against Solid Tumors

Modern science has made a tremendous amount of progress involving cancer research and treatment in the last decades. New therapies and the latest cancer treatments now include new chemotherapy agents including monoclonal antibodies. (Read up on the wonder drug known as monoclonal antibodies in this Bold story.) But despite this, the battle to fight cancer is far from over. This is especially true when it comes to solid tumors, which can be among the most aggressive. This includes cancers such as pancreatic, renal, breast and brain tumors. However, researchers may have discovered an inherent vulnerability among these cancers. And exploiting this vulnerability could lead to a completely new approach to cancer care.

As it turns out, solid tumors have some unique features that cause them to have some specific weaknesses. This is particularly true for those that grow fast and outgrow their own blood and oxygen supply. When this happens, the tumors rely on a few specific proteins and enzymes to help it survive. And by disrupting the function of these proteins and enzymes, researchers believe these tumors could be conquered. This offers great hope for solid tumor treatment care if this latest cancer treatment research is successful.

“Cancer cells depend on the CAIX enzyme to survive, which ultimately makes it their ‘Achilles heel.’ By inhibiting its activity, we can effectively stop the cells from growing.” – Shoukat Dedhar, Cancer Research Specialist

Overview of Solid Tumor Growth

There are many different types of solid tumors that may occur. In some cases, these may be surgically removed with good success. But in other instances, surgery is not an option, or the tumors are aggressive and require additional care. Current solid tumor treatment in this regard can then be limited. The medications may have trouble penetrated the extent of the tumor or simply may be poorly effective. Even the latest cancer treatment options are limited in their success in more aggressive types. This is why researchers are actively seeking better solid tumor treatment opportunities.

A doctor showing a cancer patient his artwork
A deeper understanding of what cancer needs to grow has led to a breakthrough in the fight against solid tumors.

In this regard, solid tumors do have some interesting qualities that have led to new discoveries. When solid tumors grow quickly, it is not uncommon for them to outgrow their blood supply. One might think this would lead to their demise, but that is not the case. In fact, when this does occur, the lack of oxygen to the tumor triggers the release of specific proteins. These proteins then provide alternative fuel for the solid tumor, letting it survive and spread. They also counteract the release of lactic acid and iron byproducts that would otherwise kill the cancer cells. Now that researchers understand these proteins better, they are focusing on blocking their function as the latest cancer treatment.

“At zero oxygen, the cell can’t survive. Inside a tumor you will see these regions of necrosis,” or dead cells. But those cells that are low on oxygen but still alive will produce new proteins: Key among them are HIF-1 and HIF-2.” – Daniele Gilkes, Johns Hopkins University School of Medicine.

New Solid Tumor Treatment Options

Understanding the unique growth features of some solid tumors, scientists are exploring new types of compounds. These solid tumor treatments involve various substances that affect hypoxic induction factors (HIF). Once scientists identify a specific factor, they are testing different types of solid tumor treatments. Some involve molecules that inhibit these factors while others combine a drug with an antibody. Likewise, initial studies are being performed in mice as Phase I trials. Thus far, some of these experiments are quite promising in the development of the latest cancer treatment for these tumors.

In terms of a specific solid tumor treatment, Peloton Therapeutics, Inc., has been testing one potential drug. Labelled PT2399, the drug essentially breaks one of the hypoxic induction factors in two. The specific factor has been termed HIF-2, and initial experiments have been performed in mice with renal cancer. In their experiments, the solid tumor treatment slowed growth of the cancer in 56% of mice. These results have attracted attention to this Dallas-based company. Many are hopeful this could be at least part of the latest cancer treatment combination for these types of tumors.

Peloton Therapeutics is not alone in the search for the latest cancer treatment breakthrough. Researchers out of the University of British Columbia are studying a different compound called CAIX. The substance, Carbonic Anhydrase IX, is another important protein in the hypoxic induction pathway when tumors outgrow their blood supply. Not only does CAIX help control the lactic acidosis associated with hypoxia. It also prevents cancer cells from absorbing too much iron that can lead to their demise. Researchers, however, have found that an inhibitor of CAIX, called SLC-0111, is quite powerful in its effects. Mice with brain, pancreatic, and breast cancer have all had a positive response to this solid tumor treatment.

“By understanding ferroptosis and how cells defend against it, we can develop therapeutic strategies to block those defense mechanisms and trigger cell death.” – Dr Boyi Gan, University of Texas MD Anderson Cancer Center

A New Strategy in Solid Cancer Treatment

These new discoveries of solid tumor treatment involving hypoxia pathways is certainly exciting. Drugs that could prevent these cancers from adapting to low circulation and low oxygen environments could be quite significant. If they’re unable to acquire fuel and energy, these cancer cells will cease to grow and die. This is why CAIX inhibitors and other similar drugs are being touted as the latest cancer treatment opportunity. As more pharmaceutical companies and researchers explore these options, new insights will be gained, further advancing personalized cancer care. And if results are favorable, this could be a preferred option for solid tumor treatment in the years to come.

 

The official Bold Business survey results are clear: most favor work-from-home over going back to the office. Read more in this important Bold story!

How can we help?